Department of Cardiology, Royal Free Hospital, Pond Street, London NW3 2QG, UK.
Electrophysiology Department, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK.
Europace. 2020 Nov 1;22(11):1659-1671. doi: 10.1093/europace/euaa224.
Despite recent advances in catheter ablation for atrial fibrillation (AF), pulmonary vein reconnection (PVR), and AF recurrence remain significantly high. Ablation index (AI) is a new method incorporating contact force, time, and power that should optimize procedural outcomes. We aimed to evaluate the efficacy and safety of AI-guided catheter ablation compared to a non-AI-guided approach.
A systematic search was performed on MEDLINE (via PubMED), EMBASE, COCHRANE, and European Society of Cardiology (ESC) databases (from inception to 1 July 2019). We included only studies that compared AI-guided with non-AI-guided catheter ablation of AF. Eleven studies reporting on 2306 patients were identified. Median follow-up period was 12 months. Ablation index-guided ablation had a significant shorter procedural time (141.0 vs. 152.8 min, P = 0.01; I2 = 90%), ablation time (21.8 vs. 32.0 min, P < 0.00001; I2 = 0%), achieved first-pass isolation more frequently [odds ratio (OR) = 0.09, 95%CI 0.04-0.21; 93.4% vs. 62.9%, P < 0.001; I2 = 58%] and was less frequently associated with acute PVR (OR = 0.37, 95%CI 0.18-0.75; 18.0% vs 35.0%; P = 0.006; I2 = 0%). Importantly, atrial arrhythmia relapse post-blanking was significantly lower in AI compared to non-AI catheter ablation (OR = 0.41, 95%CI 0.25-0.66; 11.8% vs. 24.9%, P = 0.0003; I2 = 35%). Finally, there was no difference in complication rate between AI and non-AI ablation, with the number of cardiac tamponade events in the AI group less being numerically lower (OR = 0.69, 95%CI 0.30-1.60, 1.6% vs. 2.5%, P = 0.39; I2 = 0%).
These data suggest that AI-guided catheter ablation is associated with increased efficacy of AF ablation, while preserving a comparable safety profile to non-AI catheter ablation.
尽管近年来在房颤(AF)的导管消融中取得了进展,但肺静脉再连接(PVR)和 AF 复发仍然很高。消融指数(AI)是一种新的方法,结合了接触力、时间和功率,应该可以优化手术结果。我们旨在评估 AI 指导下的导管消融与非 AI 指导下的方法相比的疗效和安全性。
我们在 MEDLINE(通过 PubMed)、EMBASE、COCHRANE 和欧洲心脏病学会(ESC)数据库上进行了系统搜索(从开始到 2019 年 7 月 1 日)。我们只纳入了比较 AI 指导与非 AI 指导的 AF 导管消融的研究。确定了 11 项报告 2306 例患者的研究。中位随访时间为 12 个月。AI 指导消融的手术时间明显缩短(141.0 与 152.8 分钟,P=0.01;I2=90%),消融时间缩短(21.8 与 32.0 分钟,P<0.00001;I2=0%),首次通过隔离更频繁[比值比(OR)=0.09,95%CI 0.04-0.21;93.4%与 62.9%,P<0.001;I2=58%],急性 PVR 发生率较低(OR=0.37,95%CI 0.18-0.75;18.0%与 35.0%;P=0.006;I2=0%)。重要的是,与非 AI 导管消融相比,空白期后房性心律失常复发明显降低(OR=0.41,95%CI 0.25-0.66;11.8%与 24.9%,P=0.0003;I2=35%)。最后,AI 与非 AI 消融的并发症发生率无差异,AI 组心脏压塞事件的数量较少(OR=0.69,95%CI 0.30-1.60;1.6%与 2.5%,P=0.39;I2=0%)。
这些数据表明,AI 指导下的导管消融与 AF 消融的疗效增加有关,同时与非 AI 导管消融的安全性相当。